qXR-CTR vs DeepRhythmAI
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is an automated, AI-powered solution for quickly assessing heart size and potential heart failure risk directly from chest X-ray images. This tool is ideal for radiology departments or cardiology practices seeking to streamline initial cardiac screening and identify patients who may require further investigation for cardiomegaly.
View qXR-CTR →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your focus is on revolutionizing the detection and classification of cardiac arrhythmias from ECG data with high accuracy and efficiency. This AI algorithm is best suited for cardiologists and healthcare systems aiming to significantly reduce missed diagnoses and accelerate ECG reporting workflows across a wide range of ECG devices.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | DeepRhythmAI |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing information |
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepRhythmAIDeepRhythmAI explicitly highlights its ability to streamline clinical workflows by up to 65% and offers faster ECG reporting and analysis. Additionally, web search results indicate that Medicalgorithmics products, including DeepRhythmAI, feature an intuitive user interface. While qXR-CTR automates a specific task, DeepRhythmAI's focus on workflow efficiency and user experience appears more pronounced.
Clinical Value
DeepRhythmAIBoth tools are FDA-cleared, indicating clinical validity. However, DeepRhythmAI provides compelling metrics, stating it reduces missed diagnoses by 14x to 114x and was trained on over 250 billion annotated heartbeats, demonstrating a high level of accuracy and robust validation. While qXR-CTR aids in heart failure risk assessment, it lacks comparable specific outcome metrics in the provided information.
Pricing & Value
TieBoth qXR-CTR and DeepRhythmAI have undisclosed pricing, requiring direct contact for quotes. Without publicly available pricing details or specific case studies on ROI, it is impossible to determine which tool offers better value for money.
Enterprise Readiness
qXR-CTRqXR-CTR offers flexible deployment options including cloud, on-premise, and hybrid, which is a significant advantage for large enterprises with diverse IT infrastructure and data governance requirements. It also explicitly states HIPAA compliance and BAA availability. While DeepRhythmAI has a long history and numerous global customers, its cloud-only deployment might be a limitation for some enterprise clients.
Innovation
DeepRhythmAIDeepRhythmAI demonstrates higher innovation by explicitly mentioning the use of advanced AI models like CNNs and Transformers, and being trained on an exceptionally large dataset of over 250 billion annotated heartbeats. Its device-agnostic nature also highlights a forward-thinking approach to integration. qXR-CTR's description is more functional, focusing on automated CTR measurement.
Support & Docs
TieNeither the provided structured facts nor the web search results offer specific details regarding the availability, quality, or scope of support and documentation for either qXR-CTR or DeepRhythmAI. Therefore, a distinction cannot be made between the two tools in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | DeepRhythmAI |
|---|---|---|
| Name | qXR-CTR | DeepRhythmAI |
| Company | Qure.ai Technologies | Medicalgorithmics S.A. |
| Description | qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | DeepRhythmAI is an FDA-cleared, cloud-based AI algorithm by Medicalgorithmics S.A. that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. |
| Tagline | AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. | Revolutionizing cardiac arrhythmia diagnostics with AI-powered ECG analysis. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference |
| Specialties | Cardiology, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and DeepRhythmAI.